AUTHOR=Hurkmans Evelien G. E. , Klumpers Marije J. , Dello Russo Cinzia , De Witte Ward , Guchelaar Henk-Jan , Gelderblom Hans , Cleton-Jansen Anne-Marie , Vermeulen Sita H. , Kaal Suzanne , van der Graaf Winette T. A. , Flucke Uta , Gidding Corrie E. M. , Schreuder Hendrik W. B. , de Bont Eveline S. J. M. , Caron Huib N. , Gattuso Giovanna , Schiavello Elisabetta , Terenziani Monica , Massimino Maura , McCowage Geoff , Nagabushan Sumanth , Limaye Anuja , Rose Victoria , Catchpoole Daniel , Jorgensen Andrea L. , Barton Christopher , Delaney Lucy , Hawcutt Daniel B. , Pirmohamed Munir , Pizer Barry , Coenen Marieke J. H. , te Loo D. Maroeska W. M. TITLE=Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia JOURNAL=Frontiers in Pharmacology VOLUME=13 YEAR=2023 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.980309 DOI=10.3389/fphar.2022.980309 ISSN=1663-9812 ABSTRACT=
Hearing loss (ototoxicity) is a major adverse effect of cisplatin and carboplatin chemotherapy. The aim of this study is to identify novel genetic variants that play a role in platinum-induced ototoxicity. Therefore, a genome-wide association study was performed in the Genetics of Childhood Cancer Treatment (GO-CAT) cohort (n = 261) and the United Kingdom Molecular Genetics of Adverse Drug Reactions in Children Study (United Kingdom MAGIC) cohort (n = 248). Results of both cohorts were combined in a meta-analysis. In primary analysis, patients with SIOP Boston Ototoxicity Scale grade ≥1 were considered cases, and patients with grade 0 were controls. Variants with a